Synthesis, biological evaluation and clinical trials of Cereblon-based PROTACs
Abstract PROteolysis-Targeting Chimeras (PROTACs) are an emerging class of molecules capable of inducing a forced approximation between a protein of interest (POI) and an E3 ligase enzyme (e.g., Cereblon), leading to the degradation of the POI by the cell’s own machinery. Although in early stages of...
Saved in:
| Main Authors: | André T. S. Vicente, Sara P. S. P. Moura, Jorge A. R. Salvador |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Communications Chemistry |
| Online Access: | https://doi.org/10.1038/s42004-025-01598-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unbiased mapping of cereblon neosubstrate landscape by high-throughput proteomics
by: Martin Steger, et al.
Published: (2025-08-01) -
Machine learning proteochemometric models for Cereblon glue activity predictions
by: Francis J. Prael, III, et al.
Published: (2024-12-01) -
High cereblon expression in neuroendocrine cancer confers vulnerability to GSPT1 molecular glue degrader
by: Jaewoo Park, et al.
Published: (2025-06-01) -
FDA-approved kinase inhibitors in PROTAC design, development and synthesis
by: Kacper Kossakowski, et al.
Published: (2025-12-01) -
Design, synthesis, and anti-inflammatory potential of PROTAC drug molecules based on fondaparinux sodium
by: Ruoxuan Wu, et al.
Published: (2025-07-01)